Unveiling Solutions for a Complex Ocular Condition
Thyroid Eye Disease (TED), also known as Graves' ophthalmopathy, is an autoimmune disorder characterized by inflammation and swelling of the tissues behind the eyes, leading to a range of symptoms from mild discomfort to severe vision impairment.
By Therapeutic Type:
- Marketed Treatments:
- TEPEZZA (Teprotumumab):An anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, this biologic therapy has revolutionized TED treatment.
- Retail Pharmacies: For supportive therapies and oral medications.
- Ophthalmology Clinics: Offering specialized diagnostic and treatment services.
- Rise in Cosmetically Driven Procedures:Growing demand for surgical procedures to correct the aesthetic problems caused by TED, such as eyelid surgery and strabismus surgery.
- Minimally Invasive Surgical Techniques: Advancements in surgical approaches for better cosmetic and functional outcomes.
- Telemedicine for Remote Monitoring: Adoption of telemedicine for remote patient monitoring and management of TED, enhancing accessibility.
- Artificial Intelligence (AI) in Diagnosis and Prognosis: Leveraging AI for earlier and more accurate TED diagnosis.
About Market Research Future (MRFR)Biologics Contract Development And Manufacturing Organization Cdmo Market
Market Research Future (MRFR) is a global market research firm that provides comprehensive insights into market trends, drivers, challenges, and opportunities. We offer a broad range of market intelligence reports and consulting services to help businesses and enterprises in various industries make informed decisions - Media Contact:
Market Research Future (MRFR)
Phone: +1-646-845-9312
Email: contact@marketresearchfuture.com
Website: marketresearchfuture - ? Stay ahead in the healthcare industry. Browse our latest insights now!
- Explore our latest reports
